Form F-1MEF - Registration statement to add securities to prior Form F-1 registration [Rule 462(b)]:
SEC Accession No. 0001193125-18-013542
Filing Date
2018-01-18
Accepted
2018-01-18 18:01:05
Documents
8
Effectiveness Date
2018-01-18

Document Format Files

Seq Description Document Type Size
1 F-1MEF d525818df1mef.htm F-1MEF 40182
2 EX-5.1 d525818dex51.htm EX-5.1 14865
3 EX-23.1 d525818dex231.htm EX-23.1 3995
4 GRAPHIC g525818g26u27.jpg GRAPHIC 2304
5 GRAPHIC g525818g28x78.jpg GRAPHIC 14100
6 GRAPHIC g525818g40x27.jpg GRAPHIC 17584
7 GRAPHIC g525818g56n90.jpg GRAPHIC 17587
8 GRAPHIC g525818g74m96.jpg GRAPHIC 47222
  Complete submission text file 0001193125-18-013542.txt   196798
Mailing Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007
Business Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007 972 9 770 7601
UroGen Pharma Ltd. (Filer) CIK: 0001668243 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: F-1MEF | Act: 33 | File No.: 333-222615 | Film No.: 18534977
SIC: 2834 Pharmaceutical Preparations